Predicting serum ferritin levels in patients with iron overload treated with the film-coated tablet of deferasirox during the ECLIPSE study

Am J Hematol. 2019 Jan;94(1):E15-E17. doi: 10.1002/ajh.25322. Epub 2018 Nov 15.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Blood Transfusion
  • Child
  • Clinical Trials, Phase II as Topic
  • Deferasirox / administration & dosage*
  • Deferasirox / pharmacology
  • Double-Blind Method
  • Female
  • Ferritins / blood*
  • Hematologic Diseases / blood
  • Hematologic Diseases / therapy
  • Humans
  • Iron Chelating Agents / administration & dosage*
  • Iron Chelating Agents / pharmacology
  • Iron Overload / blood
  • Iron Overload / drug therapy*
  • Iron Overload / etiology
  • Male
  • Models, Biological*
  • Multicenter Studies as Topic
  • Patient Acceptance of Health Care
  • Randomized Controlled Trials as Topic
  • Tablets
  • Young Adult

Substances

  • Iron Chelating Agents
  • Tablets
  • Ferritins
  • Deferasirox